Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits
Enthusiasm for cancer immunotherapy is soaring, and so is Arie Belldegrun’s fortune.
Dr. Belldegrun, a physician, co-founded Kite Pharma, a company that could be the first to market next year with a highly anticipated new immunotherapy treatment. But even without a product, Dr. Belldegrun has struck gold.
Home / Cancer Right / Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits